Tower Research Capital LLC (Trc) Moderna, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Moderna, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,664 shares of MRNA stock, worth $659,727. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,664

Previous 72,093 76.89%

Holding current value

$659,727

Previous $8.56 Million 87.0%

% of portfolio

0.03%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $3.53 Million - $6.94 Million	-55,429 Reduced 76.89%	16,664 $1.11 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $4.43 Million - $7.29 Million	43,763 Added 154.48%	72,093 $8.56 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $2.62 Million - $3.54 Million	-30,636 Reduced 51.96%	28,330 $3.02 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $2.65 Million - $3.98 Million	38,132 Added 183.03%	58,966 $5.86 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $116,656 - $153,198	1,210 Added 6.17%	20,834 $2.15 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $1.5 Million - $2.03 Million	12,633 Added 180.7%	19,624 $2.38 Million
Q1 2023 May 09, 2023	SELL	$135.66 - $197.02 $609,656 - $885,407	-4,494 Reduced 39.13%	6,991 $1.07 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $7.93 Million - $14.1 Million	-66,984 Reduced 85.36%	11,485 $2.06 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $2.33 Million - $3.84 Million	19,772 Added 33.68%	78,469 $9.28 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $6.51 Million - $9.81 Million	-55,552 Reduced 48.62%	58,697 $8.39 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $9.04 Million - $16.8 Million	71,508 Added 167.31%	114,249 $19.7 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $4.77 Million - $7.78 Million	21,125 Added 97.73%	42,741 $10.9 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $6.27 Million - $13.7 Million	-28,240 Reduced 56.64%	21,616 $8.32 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $3.36 Million - $6.09 Million	25,898 Added 108.1%	49,856 $11.7 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $1.96 Million - $3.34 Million	17,979 Added 300.7%	23,958 $3.14 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $342,045 - $883,781	-5,203 Reduced 46.53%	5,979 $624,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $542,802 - $947,456	9,989 Added 837.3%	11,182 $791,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $35,396 - $95,440	1,193 New	1,193 $77,000
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $178,102 - $316,336	-10,017 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$13.93 - $21.28 $76,489 - $116,848	5,491 Added 121.32%	10,017 $196,000
Q3 2019 Nov 05, 2019	BUY	$12.26 - $18.07 $55,488 - $81,784	4,526 New	4,526 $72,000
Q2 2019 Aug 13, 2019	SELL	$13.7 - $28.34 $50,813 - $105,113	-3,709 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$14.45 - $23.7 $53,595 - $87,903	3,709 New	3,709 $75,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Moderna, Inc. Transaction History